Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine are disclosed for use in the treatment of cancer, especially in the treatment of cancer where the patient shows resistance, for example, in a patient with cells with a lowered level of nucleoside transporter proteins and/or with nucleoside kinase-deficient cells and/or with mycoplasma-infected cells and/or with cells with a raised level of thymidylate synthase.
5-
氟-
2'-脱氧尿苷的
磷酰胺衍
生物被公开用于治疗癌症,特别是用于治疗患者出现抗药性的癌症,例如,患者细胞中核苷转运蛋白
水平降低和/或核苷激酶缺陷细胞和/或支原体感染细胞和/或
胸苷酸合成酶
水平升高的细胞。